Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (R

Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Human Insulin market is projected to register a robust growth during the forecast period. The growth can be attributed to the rising number of patients suffering from diabetes and growing research & development activities for drug discovery. Insulin is used to manage blood sugar levels in the body and thus reduce the symptoms of diabetes and vascular complications. According to the World Health Organization statistics, Saudi Arabia ranks seventh in the rate of diabetes. The estimates show that 7 million of the country’s population are diabetic while 3 million have pre-diabetic conditions. Increasing awareness of diabetes and advancing healthcare facilities providing treatment for chronic disorders are also propelling the growth of Saudi Arabia human insulin market. The risk of diabetes is likely to increase with growing age, and currently around 25% adults over 60 years suffer from diabetes. Thus, increasing prevalence of geriatric population is also anticipated to fuel the growth of Saudi Arabia human insulin market in the coming years. Allocation of huge funds for the healthcare, launch of new programs to educate people about diabetics by the government, and technological advancements in the field of human insulin delivery devices are likely to drive the growth of Saudi Arabia human insulin market. However, stringent regulatory requirements for the product approvals as well high manufacturing costs could restrain the growth of Saudi Arabia human insulin market. Besides, the key players are making huge investments to devise effective ways to use insulin and minimize the side-effects, which is expected to contribute to the growth of Saudi Arabia human insulin market.

The Saudi Arabia Human Insulin market is segmented on the basis of indication, route of administration, type, onset time, products, regional distribution, and company. Based on the products, the market is divided into insulin pens, insulin pumps, infusion systems, and injection. The insulin pens segment is anticipated to dominate the Saudi Arabia human insulin market due to significant reimbursements offered for human insulin pens and their continuous pipeline development & product commercialization.

Key players in Saudi Arabia human insulin market are Novo Nordisk Saudi Arabia, Sanofi Saudi Arabia, Baxter International Saudi Arabia, B Braun Saudi Arabia, Eli Lilly and Company Saudi Arabia, Pfizer Saudi Arabia, among others. Companies involved in the Saudi Arabia human insulin market are adopting competitive strategies such as partnerships, agreements, awareness campaigns, and research funding & grants to strengthen their product portfolio and sustain growth in Saudi Arabia human insulin market.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F–2027F

Objective of the Study:

• To analyze the historical growth in the market size of Saudi Arabia human insulin market from 2017 to 2021.
• To estimate and forecast the market size of Saudi Arabia human insulin market from 2022E to 2027F and growth rate until 2027F.
• To classify and forecast Saudi Arabia human insulin market based on indication, route of administration, type, onset time, products, regional distribution, and company.
• To identify dominant region or segment in the Saudi Arabia human insulin market.
• To identify drivers and challenges for Saudi Arabia human insulin market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Saudi Arabia human insulin market.
• To identify and analyze the profile of leading players operating in Saudi Arabia human insulin market.
• To identify key sustainable strategies adopted by market players in Saudi Arabia human insulin market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the Saudi Arabia. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the Saudi Arabia.

TechSci Research calculated the market size of Saudi Arabia human insulin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Human insulin developing companies
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to human insulin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Saudi Arabia Human Insulin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Human Insulin Market, By Indication:
• Type I Diabetes
• Type II Diabetes
• Saudi Arabia Human Insulin Market, By Route of Administration:
• Subcutaneous
• Nasal
• Intravenous
• Transdermal
• Oral
• Others
• Saudi Arabia Human Insulin Market, By Type:
• Basal
• Bolus
• Pre-mixed
• Biosimilar
• Traditional
• Saudi Arabia Human Insulin Market, By Onset Time:
• Rapid Acting
• Short-Acting
• Intermediate Acting
• Long Acting
• Ultra-long Acting
• Pre-Mixed
• Inhaled
• Saudi Arabia Human Insulin Market, By Products:
• Insulin Pens
• Insulin Pumps
• Infusion System
• Injection
• Saudi Arabia Human Insulin Market, By Region:
• Northern & Central
• Southern
• Eastern
• Western

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Saudi Arabia Human Insulin market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Companies Mentioned

1.Novo Nordisk Saudi Arabia
2.Sanofi Saudi Arabia
3.Baxter International Saudi Arabia
4.B Braun Saudi Arabia
5.Eli Lilly and Company Saudi Arabia
6.Pfizer Saudi Arabia

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights